Crossmark

<sup>211</sup>At-labeled immunoconjugate <i>via</i> a one-pot three-component double click strategy: practical access to α-emission cancer radiotherapeutics

Crossref DOI link: https://doi.org/10.1039/C8SC04747B

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Fujiki, Katsumasa

Kanayama, Yousuke

Yano, Shinya

Sato, Nozomi

Yokokita, Takuya

Ahmadi, Peni

Watanabe, Yasuyoshi

Haba, Hiromitsu

Tanaka, Katsunori https://orcid.org/0000-0001-6932-4802
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (JP16H03287, JP18K19154, JP17K10382, JP15H05843)

Japan Agency for Medical Research and Development (JP18am0301006)
License Information

Version of Record valid from 2018-12-21
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Katsunori Tanaka (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 25 October 2018; Accepted 19 December 2018; Accepted Manuscript published 21 December 2018; Advance Article published 4 January 2019; Version of Record published 13 February 2019

Document is current

Any future updates will be listed below